Skip to content

Immix Biopharma, Inc. IMMX Investment Purchases

Investment Purchases at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$144M-42.6%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$101.69M+102%
Precigen logo
PrecigenPGEN
$33.87M+225%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$56M-42.8%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$6.44M-65.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$139.09M+138,993%

Other financials

Income statement

See full
Operating income-$10.8M-131%
Net income-$10.1M-122%
EPS (diluted)-$0.18-20.0%

Balance sheet

See full
Cash & equivalents$79.3M+398%
Total debt$1.0M-2.0%
Total equity$84.4M+779%
Total assets$95.8M+382%

Cash flow

See full
Operating cash flow-$9.8M-483%
CapEx$32.5K-52.0%
Free cash flow-$9.9M-462%

Valuation

See full
Market cap$691.97M+1,008%
Enterprise value$613.75M+1,190%

Returns & leverage

See full
Return on equity-74.4%-18.6pp
Debt / equity-0.1×
Current ratio8.8×+7.0×

Where this comes from

Reported directly by Immix Biopharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immix Biopharma, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immix Biopharma, Inc.'s investment purchases?
Immix Biopharma, Inc. (IMMX) reported investment purchases of $7.77M in Q1 2026.
How has Immix Biopharma, Inc.'s investment purchases changed year-over-year?
Immix Biopharma, Inc.'s investment purchases increased by 379.5% year-over-year, from $1.62M to $7.77M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.